NCT04149405View on ClinicalTrials.gov

Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 6, 2017

Study Completion Date

December 28, 2018

Conditions
Osteoporosis, PostmenopausalPeriodontitis
Interventions
PROCEDURE

Phase 1 periodontal therapy

Scaling and root planning with ultrasonic and hand instruments under local anesthesia.

DRUG

Bisphosphonate therapy

Using aclasta: intravenous infusion of 5 mg of zoledronic acid once a year

All Listed Sponsors
lead

Ondokuz Mayıs University

OTHER

NCT04149405 - Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis | Biotech Hunter | Biotech Hunter